Pharvaris N.V.

PHVS chart

Pharvaris N.V. news

• Pharvaris N.V. (PHVS) Presents at 2026 HAEi Regional Conference Americas - Slideshow

  Seeking Alpha · Oct 26, 7:16 PM EDT

• Bank of America backs Pharvaris on breakthrough for rare swelling disease

  thestreet.com · Oct 26, 7:00 PM EDT

• This Tesla Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday

  Benzinga · Oct 26, 9:09 AM EDT

• Why (PHVS) Price Action Is Critical for Tactical Trading

  Stock Traders Daily · Oct 23, 9:22 PM EDT

• Two Pills, One Target: Analyst Bets on Pharvaris as Clinical Risks Fade

  Benzinga · Oct 23, 2:06 PM EDT

• Pharvaris N.V. Estimates – NASDAQ:PHVS

  TradingView · Oct 23, 10:48 AM EDT

• Norwegian downgraded, Skydance upgraded: Wall Street's top analyst calls

  Yahoo Finance · Oct 23, 9:57 AM EDT

• This Allegion Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday

  Benzinga · Oct 23, 7:37 AM EDT

• BioCryst (BCRX) Trades at Just 11x Forward Earnings. Is the Market Pricing In Trouble?

  Yahoo Finance · Oct 15, 2:05 PM EDT

• Phase 3 Study Results Highlighting Deucrictibant’s Rapid and Sustained Efficacy in Treating HAE Attacks Published in The Lancet

  Yahoo Finance · Oct 8, 6:35 PM EDT

• Could Real-World HAE Oral Preference Data Be a Pivotal Signal for Pharvaris' (PHVS) Strategy?

  Yahoo Finance · Oct 8, 11:10 AM EDT

• Real-World Analysis Highlighting HAE Disease Experience and Gaps in Treatment Satisfaction Published in Advances in Therapy

  Yahoo Finance · Oct 5, 6:50 AM EDT

Pharvaris N.V. key financials

No XBRL financial data is available for this company yet.

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 6-K6-K2026-09-08
• 6-K6-K2026-09-08
• 6-K6-K2026-08-12
• 6-K6-K2026-06-26
• 6-K6-K2026-06-11
• 6-K6-K2026-05-12
• 6-K6-K2026-05-11
• 20-F20-F2026-04-02
• 6-K6-K2026-04-02
• 6-K6-K2026-01-12
• 6-K6-K2025-12-03
• 6-K6-K2025-11-12

About Pharvaris N.V.

Ticker

PHVS (Nasdaq)

Industry

Pharmaceutical Preparations

Headquarters

Leiden

Incorporated in

Netherlands

Fiscal year end

December 31

SEC CIK

1830487

Former names

Pharvaris, B.V.

Frequently asked questions